Advocacy Actions
Submitted Comments to the National Medical Products Administration (NMPA) on Product Classification Scheme
On 28th August 2020, the Cosmetics Working Group submitted the comments to NMPA upon the Product Classification Scheme regarding articles with different opinions from member companies.
Read moreComments to the CCPIT on Provisions on the Transfer of Suspectable Criminal Cases by Administrative Organs for Law Enforcement
The Legal WG submitte comments to the CCPIT on Provisions on the Transfer of Suspectable Criminal Cases by Administrative Organs for Law Enforcement.
Read moreComments to the State Administration for Market Regulation (SAMR) on the Guiding Opinions on Strengthening the Supervision of Network Live Marketing Activities (Draft for Comments)
The European Chamber submitted collated comments to the State Administration for Market Regulation (SAMR) on the Guiding Opinions on Strengthening the Supervision of Network Live Marketing Activities (Draft for Comments)
Read moreComments to the Guangdong HSA's Draft "Ammendment to the Procedure to Modify Medical Service Pricing"
The Healthcare Equipment (HCE) Working Group submitted comments to the Guangdong Provincial Healthcare Security Administration's (HSA's) draft "Ammendment to the Procedure to Modify Medical Service Pricing".
Read moreSubmitted comments to NEA on Coal Law
On 28 August, the European Chamber's Energy and Environment working groups submitted comments to the NEA on the Coal Law of People’s Republic of China (Revised Draft).
Read moreWG Meeting with Director General Mr. Mu Changchun, Digital Currency Institute, People’s Bank of China on Digital Currency and Fintech
On 28th August, the Consumer Finance & Non-Banking Financial Institution WG organised a meeting for members to hear directly from Director General Mr. Mu Changchun of the Digital Currency Institute, People’s Bank of China.
Read moreHold Training for the Centre for Drug Re-evaluation on Post Market Surveillance in the EU with focus on the EU’s Medical Device Regulation and In Vitro Diagnostic Regulation
On 27 August, the medical device sector hold the training for he Centre for Drug Re-evaluation on Post Market Surveillance in the EU with focus on the EU’s Medical Device Regulation and In Vitro Diagnostic Regulation.
Read moreChamber leaders delivered speeches in "Connecting Shandong with Fortune Global 500 - Europe "
European Chamber Vice President Jens Eskelund spoken with Mr. Li Ganjie, Governor of Shandong Province in the main conference, while Adam Dunnett, Secretary General of the European Chamber had the online exchanges with with Mr. Zhang Shuping, Party Secretary of Yantai, Chamber founding members also participated the conference physically in the sub-venue Yantai.
Read moreSeminar and Q&A with Shenzhen Commerce Bureau and Shenzhen Taxation Bureau
On August 27th 2020, European Chamber South China Chapter co-hosted a policy interpretation seminar on 'Shenzhen’s 2020 Stabilizing Foreign Investments and Promoting Development' announcement published by the Shenzhen Municipal Government. Representatives from Shenzhen Commerce Bureau and Shenzhen Taxation Bureau brought insights on the new policies, interpreted relevant regulations and responded to foreign companies' Q&As.
Read moreLobby Letter to the State Administration for Market Regulation on Base Powder Labeling Requirement
On August 26th, the Paediatric Nutrition Desk submitted a lobby letter to the State Administration for Market Regulation (SAMR) on Article 42 in the consultation draft of Administrative Measures of Food Labeling. The Article includes a new requirement to label the base powder used in infant formula product. The lobby letter emphasized industry's analysis and concerns on this requirement and also explicated the recommendation to remove this requirement from the Administrative Measures.
Read more